• Explore /
  • Poster
  • / Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-BT).

Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-BT).

Abstract Poster

Authors

Chigusa Morizane

Chigusa Morizane

National Cancer Center Hospital, Tokyo, Japan

Chigusa Morizane , Takuji Okusaka , Junki Mizusawa , Hiroshi Katayama , Makoto Ueno , Masafumi Ikeda , Masato Ozaka , Kazuya Sugimori , Akira Fukutomi , Hiroki Hara , Nobumasa Mizuno , Hiroaki Yanagimoto , Keiji Sano , Kazutoshi Tobimatsu , Kei Yane , Shoji Nakamori , Naohiro Sata , Seigo Yukisawa , Hiroshi Ishii , Junji Furuse

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000010667

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 205)

DOI

10.1200/JCO.2018.36.4_suppl.205

Abstract #

205

Poster Bd #

A2

Abstract Disclosures

Similar Posters

First Author: Makoto Ueno

First Author: Chigusa Morizane

First Author: Aiwu He

First Author: Satoshi Nara